1996 No. 1300
The Misuse of Drugs Act 1971 (Modification) Order 1996
Made
Coming into force
At the Court at Buckingham Palace, the 15th day of May 1996
Present,
The Queen’s Most Excellent Majesty in Council
Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:
Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 19711, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:
1
This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1996 and shall come into force on 1st September 1996.
2
1
Schedule 2 to the Misuse of Drugs Act 19712 (which specifies the drugs which are subject to control under that Act) shall be amended as follows.
2
In paragraph 1 of Part III of that Schedule
a
the list of substances and products beginning with“Alprazolam”and ending with “Triazolam”shall be designated sub-paragraph (a), and accordingly “(a)”shall be inserted before “Alprazolam”; and
b
there shall be added at the end the following sub-paragraphs —
b
Atamestane.
Bolandiol.
Bolasterone.
Bolazine.
Boldenone.
Bolenol.
Bolmantalate.
Calusterone.
4-Chloromethandienone.
Clostebol.
Drostanolone.
Enestebol.
Epitiostanol.
Ethyloestrenol.
Fluoxymesterone.
Formebolone.
Furazabol.
Mebolazine.
Mepitiostane.
Mesabolone.
Mestanolone.
Mesterolone.
Methandienone.
Methandriol.
Methenolone.
Methyltestosterone.
Metribolone.
Mibolerone.
Nandrolone.
Norboletone.
Norclostebol.
Norethandrolone.
Ovandrotone.
Oxabolone.
Oxandrolone.
Oxymesterone.
Oxymetholone.
Prasterone.
Propetandrol.
Quinbolone.
Roxibolone.
Silandrone.
Stanolone.
Stanozolol.
Stenbolone.
Testosterone.
Thiomesterone.
Trenbolone.
c
any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,
i
by further substitution at position 17 by a methyl or ethyl group;
ii
by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
iii
by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
iv
by fusion of ring A with a heterocyclic system;
d
any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;
e
Chorionic Gonadotrophin (HCG).
Clenbuterol.
Non-human chorionic gonadotrophin.
Somatotropin.
Somatrem.
Somatropin.
(This note is not part of the Order)